StreetInsider.com News Articles

Form 3 Vogenx, Inc. For: Aug 11 Filed by: Wilkison William

Tue, 11 Aug 2026 20:53:00 -0400

si-local-file:///var/storage/secattach/20260811/26907604.html

Form 3 Vogenx, Inc. For: Aug 11 Filed by: Boris Timothy

Tue, 11 Aug 2026 20:52:00 -0400

si-local-file:///var/storage/secattach/20260811/26907603.html

Form 3 Vogenx, Inc. For: Aug 11 Filed by: DELMAR STEVEN R

Tue, 11 Aug 2026 20:51:00 -0400

si-local-file:///var/storage/secattach/20260811/26907601.html

Form 3 Vogenx, Inc. For: Aug 11 Filed by: Gorman Richard M

Tue, 11 Aug 2026 20:50:00 -0400

si-local-file:///var/storage/secattach/20260811/26907598.html

Form 3 Vogenx, Inc. For: Aug 11 Filed by: Cheatham Richard Bentley

Tue, 11 Aug 2026 20:49:00 -0400

si-local-file:///var/storage/secattach/20260811/26907597.html

Form 3 Vogenx, Inc. For: Aug 11 Filed by: Pieraccini Peter

Tue, 11 Aug 2026 20:48:00 -0400

si-local-file:///var/storage/secattach/20260811/26907595.html

Form 3 Vogenx, Inc. For: Aug 11 Filed by: Green James

Tue, 11 Aug 2026 20:47:00 -0400

si-local-file:///var/storage/secattach/20260811/26907593.html

Vogenx prices IPO at $13 per share, raising $81.3M

Tue, 11 Aug 2026 19:21:09 -0400

Vogenx, Inc. (NASDAQ: VOGX), a clinical-stage biopharmaceutical company, has priced its initial public offering of 6,250,000 shares of common stock at $13.00 per share, the high end of its offering range.

The company expects gross proceeds of approximately $81.3 million before deducting underwriting discounts, commissions, and other expenses. Vogenx has also granted underwriters a 45-day option to purchase up to an additional 937,500 shares at the public offering price, less underwriting discounts and commissions.

Trading on the Nasdaq Capital Market under the ticker symbol "VOGX" was expected to begin August 12, 2026, with the offering expected to close August 13, 2026, subject

Vogenx prices IPO at $13 per share, raising $81.3M

Tue, 11 Aug 2026 19:21:09 -0400

Trading on the Nasdaq Capital Market under the ticker symbol "VOGX" was expected to begin August 12, 2026, with the offering expected to close August 13, 2026, subject

Vogenx Announces Pricing of Initial Public Offering

Tue, 11 Aug 2026 19:20:00 -0400

RALEIGH, NC / ACCESS Newswire / August 11, 2026 / Vogenx, Inc. (NASDAQ:VOGX) ("Vogenx"), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis, today announced the pricing of its initial public offering of 6,250,000 shares of its common stock at the high end of the range at a public offering price of $13.00 per share. All of the shares are being offered by Vogenx. The gross proceeds to Vogenx from

Vogenx Announces Pricing of Initial Public Offering

Tue, 11 Aug 2026 19:20:00 -0400